Dr. Reddys Laboratories Ltd.

Dr. Reddys Laboratories has received the Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA), for the company’s Formulations Manufacturing Plant - 3 at Bachupally, Hyderabad.

Earlier, in February, 2019 this site had undergone an audit by the USFDA, wherein the company was issued a Form 483 with 11 observations. Based on the responses and follow up actions, the US FDA has determined the inspection classification of this facility as Voluntary Action Initiated (VAI).

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.